Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | CLBT | PAGS |
|---|---|---|
| Price | $11.20 | $10.95 |
| Change today | ▲ 1.17% | ▲ 21.40% |
| Market cap | $2.82B | $3.04B |
| Return, 3 months | -32.4% | +26.7% |
| Return, year to date | -37.9% | +19.8% |
| Return, 1 year | -40.4% | +25.5% |
| P/E (TTM) | 48.7 | 7.3 |
| P/B | 5.2 | 1.0 |
| P/E percentile vs own 5y | – | 24th |
| Dividend yield | – | 2.31% |
| Revenue growth (YoY, latest qtr) | +18.6% | – |
| Net profit growth (YoY) | +127.7% | – |
| Gross margin | 84.2% | – |
| Operating margin | 14.0% | – |
| Net margin | 16.4% | – |
| Return on equity | 19.0% | – |
| Analyst target vs. price | +45.5% | -10.3% |
| Analyst buy share | 100% | 20% |
| RSI (14) | 44 | 74 |
| 30-day volatility | 40.9% | 67.0% |
| Max drawdown, 1 year | -46.6% | -28.0% |
| Trend read | Strong downtrend | Strong uptrend |
| Analyst consensus | Buy | Hold |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
